Adaptin Bio, Inc. (APTN)
CIK 1938571 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Adaptin Bio, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 10, 2026 | 424B3 | 0001213900-26-098801 |
| Sep 9, 2026 | EFFECT | 9999999995-26-002923 |
| Aug 28, 2026 | S-1 | 0001213900-26-095034 |
| Aug 25, 2026 | 8-K | 0001213900-26-093520 |
| Aug 25, 2026 | 424B3 | 0001213900-26-093549 |
| Aug 20, 2026 | 424B3 | 0001213900-26-092107 |
| Aug 13, 2026 | 10-Q | 0001213900-26-089081 |
| Jul 22, 2026 | EFFECT | 9999999995-26-002384 |
| Jul 21, 2026 | POS AM | 0001213900-26-080096 |
| Jun 22, 2026 | D/A | 0001938571-26-000004 |
| Jun 12, 2026 | 10-K/A | 0001213900-26-068261 |
| Jun 12, 2026 | 424B3 | 0001213900-26-068357 |
| May 18, 2026 | 424B3 | 0001213900-26-058479 |
| May 15, 2026 | 10-Q | 0001213900-26-057188 |
| Apr 6, 2026 | 8-K | 0001213900-26-040458 |
| Apr 1, 2026 | 10-K | 0001213900-26-038568 |
| Apr 1, 2026 | NT 10-K | 0001213900-26-038402 |
| Mar 23, 2026 | D/A | 0001938571-26-000003 |
| Feb 20, 2026 | D/A | 0001938571-26-000002 |
| Jan 5, 2026 | D | 0001938571-26-000001 |
| Dec 23, 2025 | 8-K | 0001213900-25-125451 |
| Nov 17, 2025 | 424B3 | 0001213900-25-111384 |
| Nov 14, 2025 | 10-Q | 0001213900-25-110559 |
| Oct 7, 2025 | 424B3 | 0001213900-25-097028 |
| Oct 6, 2025 | 8-K | 0001213900-25-096532 |